IVF HARTMANN N

125.00 Fr.
0.40 %

Company specializing in sterile medical devices for the management of chronic wounds and innovative medical care treatments.

Performance & Momentum

6 Months 5.19 %
1 Year 7.91 %
3 Years 27.27 %
5 Years 9.92 %

Strategic Analysis

IVF HARTMANN N is a European specialist in sterile medical devices, focused on the management of chronic wounds and related medical care. Its positioning is based on highly technical niche solutions, with an innovative dimension that supports its foothold among healthcare institutions and care professionals.

Strengths
  • Recognized expertise in wound management and sterile products
  • Defensive positioning on a recurring, non-cyclical medical need
  • Ability to innovate in specialized segments of the medical devices market
Weaknesses
  • Exposure to a regulated and competitive healthcare market
  • Recent stock performance has been less convincing, despite a stronger intermediate-term track record
Momentum

Momentum appears solid and improving, with renewed market interest after a period of weakness over the past year. Recent dynamics suggest a gradual rerating of the stock, although the medium-term track record shows that the trajectory remains uneven and dependent on the group’s ability to turn its expertise into sustainable growth.

Similar stocks to IVF HARTMANN N

Anantys Community

Be the first to share your analysis on IVF HARTMANN N.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases